bfontana

[TimAlerts] $ONCY You guys never pay attention to these post granted orphan drug status for the Treatment of gastric cancer yesterday by the FDA a PR will post tomorrow and it will run!

bfontana

[TimAlerts] MSTX ROTH Capital initiates MSTX with a Buy and price target of $3 noting tgt based on an EPS discount model that averages firm's expected EPS ests across the first four years of co's profitability. These 2018-2021 ests are discounted by a conservative 40% discount rate, with a 30x PE applied, despite the high growth expected during these years. Co has over a year of cash, by our estimation, with no debt

bfontana

[TimAlerts] $RXII this is just the beginning of a bigger run. This company received a lot of negative PR that wasn't justified in any way, no threat of bankruptcy and a third clinical stage drug about to enter phase II. I see this moving back to $1.50+

Page
of 7